Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $21.32 USD
Change Today -0.09 / -0.42%
Volume 1.4M
BMR On Other Exchanges
Symbol
Exchange
New York
As of 8:04 PM 07/30/15 All times are local (Market data is delayed by at least 15 minutes).

biomed realty trust inc (BMR) Key Developments

BioMed Realty To Sell 65 West Watkins

BioMed Realty Trust Inc. (NYSE:BMR) has put property at 65 West Watkins Mill Road up for sale. The sale is expected to close in the third quarter of 2015.

BioMed Realty Trust Inc. Announces Unaudited Consolidated Financial Results for the Second Quarter and Six Months Ended June 30, 2015; Reports Impairment Loss for the Second Quarter of 2015; Provides Earnings and Impairment Guidance for the Year 2015

BioMed Realty Trust Inc. announced unaudited consolidated financial results for the second quarter and six months ended June 30, 2015. For the quarter, the company’s total revenues were $157,974,000 compared to $171,161,000 a year ago. Income from operations was $27,801,000 compared to $41,212,000 a year ago. Net income was $37,575,000 compared to $19,098,000 a year ago. Net income attributable to the company was $23,578,000 compared to $18,636,000 a year ago. Basic and diluted net income per share attributable to common stockholders was $0.11 compared to $0.10 for the same period a year ago. Diluted FFO available to common shares and units was $120,811,000 or $0.58 per share compared to $83,378,000 or $0.40 per share a year ago. AFFO available to common shares and units was $100,218,000 or $0.48 per share compared to $67,741,000 or $0.84 per share a year ago. Diluted CFFO available to common shares and units was $121,911,000 or $0.58 per share compared to $84,512,000 or $0.40 per share a year ago. For the six month, the company’s total revenues were $335,984,000 compared to $340,037,000 a year ago. Income from operations was $56,940,000 compared to $81,964,000 a year ago. Net income was $58,356,000 compared to $39,865,000 a year ago. Net income attributable to the company was $40,923,000 compared to $37,469,000 a year ago. Basic and diluted net income per share attributable to common stockholders was $0.20 compared to $0.19 for the same period a year ago. Diluted FFO available to common shares and units was $206,070,000 or $0.99 per share compared to $166,760,000 or $0.81 per share a year ago. AFFO available to common shares and units was $175,992,000 or $0.84 per diluted share compared to $147,493,000 or $0.71 per diluted share a year ago. Diluted CFFO available to common shares and units was $207,634,000 or $0.99 per share compared to $169,144,000 or $0.80 per share a year ago. In the quarter, the company recorded an impairment loss of $35.1 million, primarily as a result of the sale of its King of Prussia property in Radnor, Pennsylvania for approximately $35.2 million in gross proceeds. For the year 2015, the company projected net income per diluted share available to common stockholders between $0.36 to $0.42, FFO per diluted share between $1.74 to $1.80 and project CFFO per diluted share in between $1.75 to $1.81. The company expects real estate depreciation and amortization of $1.21 and impairment of real estate, net of 0.16. The company's 2015 FFO and CFFO estimates reflect the impact of previously announced new investments and dispositions. The foregoing estimates also include the impact of: (i) lease terminations recorded through the six months ended June 30, 2015, aggregating $16.2 million, or $0.08 per diluted share, (ii) investment gains and losses, net of an allocation of income attributable to noncontrolling interests, estimated for the full year 2015 to be approximately $76.7 million, or $0.37 per diluted share, and (iii) the impact of the new development project in Providence, Rhode Island. These estimates also do not include the effect of any other lease termination revenue or investment gains or losses.

BioMed Realty Trust Inc., Q2 2015 Earnings Call, Jul 29, 2015

BioMed Realty Trust Inc., Q2 2015 Earnings Call, Jul 29, 2015

BioMed Realty Trust Inc. to Report Q2, 2015 Results on Jul 28, 2015

BioMed Realty Trust Inc. announced that they will report Q2, 2015 results at 5:00 PM, Eastern Standard Time on Jul 28, 2015

BioMed Realty Trust, Inc. and Illumina Signs 20-Year Lease for New and Innovative Scientific Research Building in Cambridge, England

BioMed Realty Trust Inc. announced that Illumina Inc. has signed a 20-year lease for a 155,000 square foot new and innovative scientific research building in Cambridge, England. The project will provide Illumina a collaborative environment and access to the highly skilled workforce in the dynamic research cluster anchored by Cambridge University. The project advances design, with plans to be able to seamlessly expand by 70,000 square feet into a 225,000 square foot building. BioMed Realty acquired the land for the project from The Welding Institute under a long term ground lease, enlarging BioMed Realty'sGranta Park campus in Cambridge, England.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BMR:US $21.32 USD -0.09

BMR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alexandria Real Estate Equities Inc $92.60 USD -0.99
American Campus Communities Inc $37.09 USD -0.72
Douglas Emmett Inc $29.20 USD -0.05
Equity LifeStyle Properties Inc $57.45 USD +0.03
Home Properties Inc $73.40 USD -0.04
View Industry Companies
 

Industry Analysis

BMR

Industry Average

Valuation BMR Industry Range
Price/Earnings 23.3x
Price/Sales 6.6x
Price/Book 1.4x
Price/Cash Flow 9.6x
TEV/Sales 2.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOMED REALTY TRUST INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.